Tagged with Middle East

Middle East & Africa Mediclinic Middle East’s CEO David Hadley explains the UAE’s response to the pandemic and how Mediclinic was involved. He also discusses the oversupply of hospitals and other healthcare trends in the region. The pandemic encouraged people to focus more on their health in one way or another. This creates the…

UAE Mohamed Galal, VP and Head of Bayer’s Consumer Health Division in the Middle East, draws upon his 16 years of experience with the company to discuss their digitalization approach to position themselves as the partner of choice. Moreover, he reveals how the UAE is taking an innovative approach to addressing…

UAE Ana Raposo, country director for Gulf Countries at Janssen discusses her role, the main similarities and differences between the various markets throughout the Gulf, mental health, and corporate social responsibility (CSR) initiatives in the region.   The Gulf markets are very open to innovation and eager to bring the most…

UAE The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates the process and eliminates long waiting times for innovative and orphan drugs.   If you bring innovation, the [UAE] government will support you on all levels Georg Schroeckenfuchs, Novartis In January 2018…

UAE PharmaBoardroom highlights three pharma executives whose experience in the Middle East has served to propel them into global leadership positions.   The Middle East and North Africa region is comprised of 22 countries and has a population of nearly 400 million. The region is home to a fast-growing pharma market…

UAE The top 10 pharma companies in the UAE ranked by 2018 sales according to IQVIA data. Swiss giant Novartis leads the way with USD 196 million in sales, followed by GSK on 129 million and AstraZeneca with 126 million.   Made with Visme Infographic Maker

Rankings The MEA market has reached $25B in value, growing at 8% CAGR; short term growth stood at 10% from 2017 to 2018. Saudi Arabia, the largest market in MEA at $8.2B in value, grew at 7% in value terms. Egypt, Algeria and UAE are other large markets that had double-digit…

MEA These 10 corporations represent 37% of the MEA market by value. Novo Nordisk’s USD 635M growth is mainly driven by Norditropin (somatropin), Victoza (liraglutide) & Saxenda (liraglutide) which have grown at 60%, 18% and 190% PPG respectively. Hikma’s USD 497M growth has been the fastest due to Remox (amoxicillin) and…

Turkey Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has implemented in Turkey and its successes, provides insights into future collaborations and discusses the importance of a holistic approach focusing on preventive technologies.   Having a holistic approach across healthy living, prevention, diagnostic,…

Malaysia How Malaysia is setting itself up to provide biosimilars across the Islamic world as well as Asia.   Inno Bio Ventures, a Malaysian state-owned company originally set up to create drug security by ensuring that the country was self-sufficient in terms of medicine supply, has been making its first moves…

Pharma Ten years after his first interview with Focus Reports, Wafik Bardissi discusses Minapharm’s position as the leading biosimilar manufacturer in the Middle East. Has Egypt taken steps to incentivize the development or registration of biosimilar products? At present, more attention is required in Egypt to promote biosimilar development or encourage the registration of…

Pharma Fresenius Kabi’s general manager for the MENA region discusses evolving attitudes towards clinical nutrition for critically ill patients and Egypt’s positioning as a knowledge center and source of medical professionals at the regional level. Fresenius is the undisputed provider of critical care worldwide. What products do you offer in Egypt…